Leo Mavely – Axio Biosolutions
View Detailed Executive Profile →Professional Overview
- Leo Mavely is the Founder and CEO of Axio Biosolutions Private Limited, a company established in May 2008, focusing on innovative healthcare solutions.
- Under Mavely's leadership, Axio Biosolutions developed advanced medical products, particularly in the field of wound care, contributing to improved patient outcomes.
- The organization gained recognition for its commitment to research and development, leading to the introduction of several patented medical technologies.
- In May 2016, Mavely took on the role of President at Advamedica Inc., expanding the influence and operations within the biotech industry.
- A significant achievement includes Axio Biosolutions' notable partnerships with various healthcare institutions and stakeholders, facilitating the widespread adoption of its products.
- Mavely navigated challenges such as market competition and regulatory requirements while ensuring the company's growth and sustainability in the healthcare sector.
- The emphasis on quality and compliance under Mavely's guidance has helped Axio Biosolutions establish a strong reputation and achieve several industry certifications.
- As an incubatee at NirmaLabs from April 2007 to May 2008, Mavely leveraged the incubation support to refine the business model and operational strategies for Axio Biosolutions.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| NirmaLabs | Incubatee | Apr 2007 – May 2008 |
| Advamedica Inc. | President | May 2016 – Present |
| Axio Biosolutions Private Limited | Founder and CEO | May 2008 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Axio Biosolutions corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Leo Mavely's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Axio Biosolutions's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)